See the power of our technology in action! Request a demo 
hospital at home
Connecting care teams with patients to provide remote care for those who have long-term conditions. This eases pressure on healthcare systems and empowers patients to improve their health.
Using Huma’s technology, healthcare systems are supporting each patient to manage their chronic disease and improve their quality of life and health outcomes.
Huma in partnership with Discover-NOW, health data research hub for real world evidence, and Know Diabetes are enabling remote care for people living with type 2 diabetes. Together we are utilising real world data to support high-quality research, with the ambition of transforming care pathways for patients with type 2 diabetes.
0kgaverage
weight loss1
patient
adherence rate1
0mmol/molaverage reduction
in HbA1c1
Many patients require long-term care to monitor and manage their illness.
The Royal Brompton NHS hospital uses our 'hospital at home' technology to care for people born with complex congenital heart disease who require frequent and regular assessments.
Using our technology the clinical teams can remotely monitor patients wherever they are and engage them closely in their own health management.
Huma is currently working with Bayer, Stanford Medicine and the Stanford Center for Digital Health (CDH) to validate an approach to decentralize the clinical trial experience for patient participants with atrial fibrillation. The study aims to prove the feasibility, acceptability, and best practices that can achieve high compliance, quality, and scientifically sound fully remote clinical trials.
94% of participants
recruited in 12 days2
Increased oral anticoagulation adherence from 85% to 96% in patients with low baseline adherence2
Participant
retention2
personalised care
news
1. Data from 2021 pilot study. Full evaluation of the service is in preparation.
2. Data from 2021 single-arm, six-month study. Paper in submission.
3. Huma is committed to respecting your privacy, and we’ll only use your personal details to send you the Huma Healthcare Guide. You can review our Privacy Policy for further information.
How decentralized and hybrid trials can drive efficiencies beyond the pandemic
Huma’s Nico O'Kuinghttons discusses how we can drive more efficient decentralized and hybrid clinical trials post-pandemic